4-fluoro-4-methyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine
Structure Info
- Chemspace ID
- CSSB02229496210 (In-Stock Building Blocks)
- IUPAC Name
- 4-fluoro-4-methyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine
- Mol formula
- C19H27BFNO3
- Mol weight
- 347 Da
- Catalog Number(s)
- BBLS02229496210, BBV-288318030, EN300-55169571, bbls02229496210
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.28
- Heavy atoms count
- 25
- Rotatable bond count
- 2
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.631
- Polar surface area (Å)
- 39
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 0
![Chemical structure of 4-fluoro-4-methyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine (C19H27BFNO3) - CSSB02229496210](/st/structure/200/b5c1f6b969b691e3cc9e46259efb8ed0/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC%2528C%2529%2528F%2529CC1.png "C19H27BFNO3")
- Zoom the structure
- CSSB02229496210
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 360.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 376.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 393.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 410.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 427.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 838.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,240.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 1,839.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of 6-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]-6-azaspiro[2.5]octane - CSSB02229499312](/st/structure/200/e9309e052a14d770d1c430b1bbf22103/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC2%2528CC2%2529CC1.png)
![Chemical structure of 4,4-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]piperidine - CSSB02229493961](/st/structure/200/ea29fb2148594f2d3c69a2c8f7bcaab1/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC%2528C%2529%2528C%2529CC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azetidine - CSSB00010725094](/st/structure/200/ac337900ce77096ee5111ca3dbcbcc73/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]pyrrolidine - CSSB00000062365](/st/structure/200/e8d1292d78042a13303164e90789e718/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCC1.png)
![Chemical structure of 4-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]morpholine - CSSB00015191535](/st/structure/200/b0e02387193158699adbf95d83b7d7dc/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCOCC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azepane - CSSB02195991377](/st/structure/200/848db6b26cd4308fbbf8ce9eaba6da5a/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCCCC1.png)
![Chemical structure of 1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzoyl]azocane - CSSB02229500790](/st/structure/200/c323fbd8d45c2188306a14a408fcc5c3/CC1%2528C%2529OB%2528OC1%2528C%2529C%2529C1%253DCC%253DCC%2528%253DC1%2529C%2528%253DO%2529N1CCCCCCC1.png)
